ERBB2 and breast cancer: Among the four molecular subtypes of breast cancer, estrogen receptor (ER) and/or progesterone receptor (PR) + and human epidermal growth factor receptor 2 (HER2)− occurred most commonly and account for approximately 60% of breast cancer patients [12].